Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (DREAMS) in Patients With De-Novo Coronary Lesions: 12 Month Results of the Prospective, Multicentre, First-in-Man BIOSOLVE-I Trial

Study Questions:

What is the safety and efficacy of a drug-eluting absorbable metal stent?